Novel compounds selected from 2-(3-aminoaryl) amino-4-aryl-thiazoles of formula (I) that selectively modulate, regulate, and/or inhibit signal transductions mediated by certain native and/or mutant tyrosine kinases implicated in a variety of human and animal diseases such as cell proliferative, metabolic, allergic and degenerative disorders. More particularly, these compounds are potent and selective c-kit inhibitors.

 
Web www.patentalert.com

< Combination of proton pump inhibitor, buffering agent, and prokinetic agent

< Substituted benzoxazoles as estrogenic agents

> Body weight gain inhibitors

> Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation

~ 00217